AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Cyera doubles valuation to $3B with $300M Series D, total funding hits $600M in seven months
2
Wiz acquires Dazz for $450 million to strengthen AI-driven cloud security
3
Claroty veterans launch Twine with $12M in Seed funding from Dell and Wiz founders to deploy AI cyber workers
4
Salesforce seals $1.9 billion cash deal to acquire cloud backup company Own
5
Prompt Security raises $18 million Series A to protect enterprises from GenAI risks
More news

Enlivex

4 stories about Enlivex
מחלקת קורונה בית חולים איכילוב תל אביב 1

Jerusalem-based Enlivex reports promising results in treating small number of Covid-19 patients

01.10.20|Reuters
Five patients in severe or critical condition make full recoveries in under 10 days after receiving drug as part of clinical trial
תרגיל מסכם לקראת הגעת הגעתם של ישראלים מ ספינת הקורונה נגיף קורונה בית חולים שיבא תל השומר

Enlivex Leveraged Coronavirus to Get Money out of Shareholders

26.02.20|Uri Tal-Tene
The company announced on Monday a plan to increase the manufacturing capacity for its experimental drug “in preparation for potential requests for treatment of coronavirus patients” and used the resulting stock boost to raise a direct offering of $8 million
שי נוביק יו"ר אנלייבקס

CEO of Nasdaq-Listed Cell Immunotherapy Company Enlivex Steps Down

02.10.19|Tzally Greenberg
Enlivex develops cell-based treatments for life-threatening immune and inflammatory conditions, such as graft versus host disease, a post bone marrow transplant complication
נאסדק

Cell Immunotherapy Company Enlivex Merges With Nasdaq-Listed Bioblast, Raises $5.3 Million

28.03.19|Lilach Baumer
The merged entity listed on Nasdaq under the ticker “ENLV”